Skip to main content
Log in

Bortezomib therapy at home for MM: cost effective and preferred

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Lassalle A, et al. Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared to hospital administration: results of a prospective single-center study. Annals of Oncology : 16 Nov 2015. Available from: URL: http://doi.org/10.1093/annonc/mdv563

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bortezomib therapy at home for MM: cost effective and preferred. PharmacoEcon Outcomes News 742, 16 (2015). https://doi.org/10.1007/s40274-015-2644-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2644-2

Navigation